Core Laboratories Income Statement
CLB / Energy|5 years of annual SEC 10-K data (FY2021-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
Core Laboratories reported $527M in revenue and $30M in net income for FY2025. Revenue has grown at a 2.9% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $526.5M | $523.8M | $509.8M | $489.7M | $470.3M |
| Cost of Revenue | $417.6M | $420.5M | $400.0M | $393.7M | - |
| SG&A Expense | $45.4M | $39.8M | $40.3M | $38.1M | - |
| Operating Income | $56.5M | $58.6M | $54.6M | $41.5M | $45.3M |
| Interest Expense | $10.6M | $12.4M | $13.4M | $11.6M | $9.2M |
| Income Tax | $15.5M | $14.0M | $4.2M | $10.3M | $15.9M |
| Net Income | $29.7M | $31.4M | $36.7M | $19.5M | $19.7M |
| EPS (Basic) | $0.79 | $0.42 | $0.43 | $0.42 | $0.43 |
| EPS (Diluted) | $0.77 | $0.42 | $0.42 | $0.42 | $0.42 |
| Shares Outstanding | 46.8M | 46.9M | 46.6M | 46.8M | 46.7M |
| Operating Margin | 10.7% | 11.2% | 10.7% | 8.5% | 9.6% |
| Profit Margin | 5.6% | 6.0% | 7.2% | 4.0% | 4.2% |